Nagy A. Farid

Identification of the Human Cytochrome P450 Enzymes Involved in the Two Oxidative Steps in the Bioactivation of Clopidogrel to Its Pharmacologically Active Metabolite

Miho Kazui, Yumi Nishiya, Tomoko Ishizuka et al. · Drug Metabolism and Disposition · 2009 · 808 citations

A comparison of prasugrel and clopidogrel loading doses on platelet function: magnitude of platelet inhibition is related to active metabolite formation

John T. Brandt, Christopher D. Payne, Stephen D. Wiviott et al. · American Heart Journal · 2006 · 568 citations

Thrombopoiesis, Thrombosis, Clopidogrel Loading Doses +12

Effects of the Proton Pump Inhibitor Lansoprazole on the Pharmacokinetics and Pharmacodynamics of Prasugrel and Clopidogrel

David S. Small, Nagy A. Farid, Christopher D. Payne et al. · The Journal of Clinical Pharmacology · 2008 · 315 citations

Thrombopoiesis, Molecular Pharmacology, Thrombosis +15

INTERACTIONS OF TWO MAJOR METABOLITES OF PRASUGREL, A THIENOPYRIDINE ANTIPLATELET AGENT, WITH THE CYTOCHROMES P450

Jessica Rehmel, James A. Eckstein, Nagy A. Farid et al. · Drug Metabolism and Disposition · 2006 · 263 citations

The Disposition of Prasugrel, a Novel Thienopyridine, in Humans

Nagy A. Farid, Richard L. Smith, Todd A. Gillespie et al. · Drug Metabolism and Disposition · 2007 · 211 citations